Excessive proliferation and stabilization of the microtubule (MT) array in cardiac myocytes can accompany pathological cardiac hypertrophy, but the molecular control of these changes remains poorly characterized. In this study, we examined MT stabilization in two independent murine models of heart failure and revealed increases in the levels of post-translationally modified stable MTs, which were closely associated with STAT3 activation. To explore the molecular signaling events contributing to control of the cardiac MT network, we stimulated cardiac myocytes with an ␣-adrenergic agonist phenylephrine (PE), and observed increased tubulin content without changes in detyrosinated (glutubulin) stable MTs. In contrast, the hypertrophic interleukin-6 (IL6) family cytokines increased both the glu-tubulin content and glu-MT density. When we examined a role for ERK in regulating cardiac MTs, we showed that the MEK/ERK-inhibitor U0126 increased glu-MT density in either control cardiac myocytes or following exposure to hypertrophic agents. Conversely, expression of an activated MEK1 mutant reduced glu-tubulin levels. Thus, ERK signaling antagonizes stabilization of the cardiac MT array. In contrast, inhibiting either JAK2 with AG490, or STAT3 signaling with Stattic or siRNA knockdown, blocked cytokine-stimulated increases in glu-MT density. Furthermore, the expression of a constitutively active STAT3 mutant triggered increased glu-MT density in the absence of hypertrophic stimulation. Thus, STAT3 activation contributes substantially to cytokine-stimulated glu-MT changes. Taken together, our results highlight the opposing actions of STAT3 and ERK pathways in the regulation of MT changes associated with cardiac myocyte hypertrophy.In cardiac myocytes, the microtubule (MT) 5 array comprises a major cytoskeletal element. MT organization changes between phases of assembly/disassembly with either fast (dynamic) or slow (stable) kinetics. MT stability can be regulated through direct association and regulation by numerous proteins such as MT-associated proteins (MAPs), plus-end tracking proteins (ϩTIPs) and tubulin-sequestering negative regulators of MT assembly (e.g. stathmins) (1-3). In turn, these direct modulators of MT stability are regulated by multisite phosphorylation by various kinases thus linking changes in MT dynamics with extracellular stimuli (2, 3). Furthermore, once assembled, tubulin polymers are modified by the addition of acetyl groups on Lys-40 (acetyl-tubulin) and the reversible removal of tyrosine from the ␣-tubulin C terminus (named glu-tubulin for the penultimate glutamate revealed) (4, 5). Post-translational modification of tubulin occurs as a direct function of the time a tubulin heterodimer spends in the polymerized state and therefore reports on MT age. Although not directly contributing to the stabilization of MTs per se, these modifications are markers of stabilized MTs that turnover slowly. In neurons, protein kinases such as the c-Jun N-terminal kinases and microtubule affinity-regulating kinases h...